Cannvas MedTech Inc. (CSE:MTEC) , a leading business technology company within the cannabis space, is pleased to announce that it has acquired over 650 online domains since the inception of the Company. The majority of these domains will be used for marketing awareness and customer acquisition as the Company rolls out its global expansion plan for the Cannvas.me platform.

“Our domain strategy is one of many important components of an overall global marketing plan, as we begin the socialization of our cannabis education platform with a goal of achieving user acquisition targets,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “Marketing and customer acquisition efforts will be further emphasized through targeted CRM strategies as the Cannvas.me platform is phased into global markets. Reaching a broad base of users and engaging them through meaningful and contextual content will ensure a healthy base for deriving cannabis sector insights on a global economic scale, directly tying into our financial partnership models for company growth targets and positive financial outcomes.”

An example of the contextual nature of the platform is the use of the .me extension. Originally the extension was the domain of the country of Montenegro, but it’s become commonplace and popular to use it for personal and customer-centric sites. They are ideal for promoting products or services to a internet-savvy web consumers.


About Cannvas.me

Cannvas.me is an innovative and unbiased online health sciences educational platform where patients can take an active role in defining the path of control of their health and wellness through the use of cannabis. It is a scalable and comprehensive solution for the global cannabis community offering interactive tools and physician-backed content. It takes an innovative approach to place cannabis education at the forefront by bringing design, creativity, data aggregation and global connectivity to new heights. Through subsidiaries Cannvas Creative, Cannvas Data and Cannvas Connect; Cannvas.me will feature innovative tools such as educational learning modules in its Cannvas University, an interactive Cannvas Strain Matcher  that educates audiences with specific ailments, and Cannvas Culinary, for those wishing to learn about the culinary approach to treatments.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

Click here to connect with Cannvas MedTech Inc. (CSE:MTEC) for an Investor Presentation

Source: www.newswire.ca

Ensuring estoraTMpatients have seamless access to their high-quality medical cannabis products

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announce that its subsidiary Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, has partnered with CannTrust Inc. to bring same-day and next-day delivery to estoraTM medical cannabis patients in Ontario

Keep reading... Show less

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less